Smad3, a transcription factor, upregulates the transcription of PTHLH by binding to the proximal PTHLH promoter region in response to TGFβ1 signalling in breast cancer cells and consequently promotes bone metastasis [17]. Here, SMAD3 is linked to breast carcinoma.